UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 212

Sortiert nach

G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin

Nature communications, 2017-08, Vol.8 (1), p.274-14, Article 274

2017

Volltextzugriff (PDF)

PI3Kα inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment

Cancer letters, 2019-09, Vol.459, p.145-155

2019

Volltextzugriff (PDF)

CTC clusters induced by heparanase enhance breast cancer metastasis

Acta pharmacologica Sinica, 2018-08, Vol.39 (8), p.1326-1337

2018

Volltextzugriff (PDF)

Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3

Acta pharmacologica Sinica, 2018-12, Vol.39 (12), p.1885-1893

2018

Volltextzugriff (PDF)

SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors

Acta pharmacologica Sinica, 2021-06, Vol.42 (6), p.998-1004

2021

Volltextzugriff (PDF)

A novel tricyclic BTK inhibitor suppresses B cell responses and osteoclastic bone erosion in rheumatoid arthritis

Acta pharmacologica Sinica, 2021-10, Vol.42 (10), p.1653-1664

2021

Volltextzugriff (PDF)

Author Correction: G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin

Nature communications, 2020-07, Vol.11 (1), p.1-3, Article 3789

2020

Volltextzugriff (PDF)

CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression

Acta pharmacologica Sinica, 2019-05, Vol.40 (5), p.677-688

2019

Volltextzugriff (PDF)

SAF-248, a novel PI3Kδ-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma

Acta pharmacologica Sinica, 2022-01, Vol.43 (1), p.209-219

2022

Volltextzugriff (PDF)

EPHA2 feedback activation limits the response to PDEδ inhibition in KRAS-dependent cancer cells

Acta pharmacologica Sinica, 2020-02, Vol.41 (2), p.270-277

2020

Volltextzugriff (PDF)

Antitumor pharmacological research in the era of personalized medicine

Acta pharmacologica Sinica, 2022-12, Vol.43 (12), p.3015-3020

2022

Volltextzugriff (PDF)

Evaluation of in vitro and in vivo activity of a multityrosine kinase inhibitor, AL3810, against human thyroid cancer

Acta pharmacologica Sinica, 2017-11, Vol.38 (11), p.1533-1542

2017

Volltextzugriff (PDF)

Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease

Acta pharmacologica Sinica, 2011-05, Vol.32 (5), p.545-551

2011

Volltextzugriff (PDF)

Identification of compound D2923 as a novel anti-tumor agent targeting CSF1R

Acta pharmacologica Sinica, 2018-11, Vol.39 (11), p.1768-1776

2018

Volltextzugriff (PDF)

Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors

Acta pharmacologica Sinica, 2016-05, Vol.37 (5), p.698-707

2016

Volltextzugriff (PDF)

One-pot N-glycosylation remodeling of IgG with non-natural sialylglycopeptides enables glycosite-specific and dual-payload antibody-drug conjugates

Organic & biomolecular chemistry, 2016-10, Vol.14 (40), p.9501-9518

2016

Volltextzugriff (PDF)

Naturally Occurring Homoisoflavonoids Function as Potent Protein Tyrosine Kinase Inhibitors by c-Src-Based High-Throughput Screening

Journal of medicinal chemistry, 2008-08, Vol.51 (15), p.4419-4429

2008

Volltextzugriff (PDF)

Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells

Acta pharmacologica Sinica, 2016-12, Vol.37 (12), p.1587-1596

2016

Volltextzugriff (PDF)

DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo

Acta pharmacologica Sinica, 2016-03, Vol.37 (3), p.398-407

2016

Volltextzugriff (PDF)

Oligomannurarate sulfate inhibits CXCL12/SDF-1- mediated proliferation and invasion of human tumor cells in vitro

Acta pharmacologica Sinica, 2013-12, Vol.34 (12), p.1554-1559

2013

Volltextzugriff (PDF)

R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II

Molecular cancer therapeutics, 2007-02, Vol.6 (2), p.484-495

2007

Volltextzugriff (PDF)

Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells

Acta pharmacologica Sinica, 2014-01, Vol.35 (1), p.89-97

2014

Volltextzugriff (PDF)

Pseudolarix Acid B, a New Tubulin-Binding Agent, Inhibits Angiogenesis by Interacting with a Novel Binding Site on Tubulin

Molecular pharmacology, 2006-04, Vol.69 (4), p.1226-1233

2006

Volltextzugriff (PDF)

Salvicine Functions as Novel Topoisomerase II Poison by Binding to ATP Pocket

Molecular pharmacology, 2006-11, Vol.70 (5), p.1593-1601

2006

Volltextzugriff (PDF)

Cytotoxic sesquiterpenoids from Sarcandra glabra

Tetrahedron, 2013-01, Vol.69 (2), p.564-569

2013

Volltextzugriff (PDF)

1 – 25 von 212

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(194)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(124)
Life Sciences & Biomedicine
(87)
Humans
(72)
Physical Sciences
(56)
Animals
(49)
Chemistry
(46)
Pharmacology & Pharmacy
(45)
Chemistry, Multidisciplinary
(31)
Female
(25)
Cell Line, Tumor
(24)
Male
(23)
Mice
(19)
Original
(18)
Molecular Structure
(17)
Biological And Medical Sciences
(16)
Cell Proliferation - Drug Effects
(16)
Antineoplastic Agents - Pharmacology
(15)
Technology
(15)
Apoptosis
(14)
Medical Sciences
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin

PI3Kα inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment

CTC clusters induced by heparanase enhance breast cancer metastasis

Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3

SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors

A novel tricyclic BTK inhibitor suppresses B cell responses and osteoclastic bone erosion in rheumatoid arthritis

Author Correction: G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin

CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression

SAF-248, a novel PI3Kδ-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma

EPHA2 feedback activation limits the response to PDEδ inhibition in KRAS-dependent cancer cells

Antitumor pharmacological research in the era of personalized medicine

Evaluation of in vitro and in vivo activity of a multityrosine kinase inhibitor, AL3810, against human thyroid cancer

Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease

Identification of compound D2923 as a novel anti-tumor agent targeting CSF1R

Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors

One-pot N-glycosylation remodeling of IgG with non-natural sialylglycopeptides enables glycosite-specific and dual-payload antibody-drug conjugates

Naturally Occurring Homoisoflavonoids Function as Potent Protein Tyrosine Kinase Inhibitors by c-Src-Based High-Throughput Screening

Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells

DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo

Oligomannurarate sulfate inhibits CXCL12/SDF-1- mediated proliferation and invasion of human tumor cells in vitro

R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II

Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells

Pseudolarix Acid B, a New Tubulin-Binding Agent, Inhibits Angiogenesis by Interacting with a Novel Binding Site on Tubulin

Salvicine Functions as Novel Topoisomerase II Poison by Binding to ATP Pocket

Cytotoxic sesquiterpenoids from Sarcandra glabra

Suchergebnisse filtern